Stroma Genomic Signature Predicts Resistance To Anthracyclin-based Chemotherapy In Breast Cancer
Tuesday, February 3, 2009 - 10:42
in Health & Medicine
Researchers have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.